Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than non‐alcoholic fatty liver disease
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-12-31
DOI
10.1111/liv.15508
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence trends of non-alcoholic fatty liver disease among young men in Korea: A Korean military population-based cross-sectional study
- (2022) Jaejun Lee et al. Clinical and Molecular Hepatology
- MAFLD Predicts the Risk of Cardiovascular Disease Better than NAFLD in Asymptomatic Subjects with Health Check-Ups
- (2022) Hyoeun Kim et al. DIGESTIVE DISEASES AND SCIENCES
- The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease
- (2022) Cheng Han Ng et al. Clinical and Molecular Hepatology
- NAFLD increases Risk of Carotid Atherosclerosis and Ischemic Stroke. An Updated Meta-Analysis with 135,602 Individuals
- (2022) Ansel Shao Pin Tang et al. Clinical and Molecular Hepatology
- NAFLD versus MAFLD: Prevalence, Outcomes and Implications of a Change in Name
- (2022) Cheng Han Ng et al. Clinical and Molecular Hepatology
- The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults
- (2022) Jun-Hyuk Lee et al. Clinical and Molecular Hepatology
- HCC Surveillance in Patients with NAFLD
- (2022) Karim Seif El Dahan et al. Clinical and Molecular Hepatology
- Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
- (2022) Michael H. Le et al. Clinical and Molecular Hepatology
- Non-Alcoholic Fatty Liver Disease: From Pathogenesis to Clinical Impact
- (2021) Alfredo Caturano et al. Processes
- Mechanisms of Non-Alcoholic Fatty Liver Disease in the Metabolic Syndrome. A Narrative Review
- (2021) Luca Rinaldi et al. Antioxidants
- Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
- (2021) Ferdinando Carlo Sasso et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
- (2021) Seong Hee Kang et al. Clinical and Molecular Hepatology
- MAFLD Enhances Clinical Practice for Liver Disease in the Asia-Pacific region
- (2021) Takumi Kawaguchi et al. Clinical and Molecular Hepatology
- Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
- (2020) Luigi Elio Adinolfi et al. ATHEROSCLEROSIS
- FibroScan-AST (FAST) score for the non-invasive identification of patients with non-alcoholic steatohepatitis with significant activity and fibrosis: a prospective derivation and global validation study
- (2020) Philip N Newsome et al. Lancet Gastroenterology & Hepatology
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Prevalence and Risk Factors of Metabolic Associated Fatty Liver Disease in Xinxiang, China
- (2020) Hongbin Li et al. International Journal of Environmental Research and Public Health
- Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antivirals therapy. A prospective study.
- (2020) Luigi E Adinolfi et al. DIABETES OBESITY & METABOLISM
- Comparison of MAFLD and NAFLD diagnostic criteria in real world
- (2020) Su Lin et al. LIVER INTERNATIONAL
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLD
- (2020) Sakura Yamamura et al. LIVER INTERNATIONAL
- Evaluation and Management of Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease
- (2020) Karn Wijarnpreecha et al. Clinical and Molecular Hepatology
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Alcohol Consumption and Risk of Liver Cirrhosis
- (2019) Michael Roerecke et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Non-invasive assessment of non-alcoholic fatty liver disease: Clinical prediction rules and blood-based biomarkers
- (2018) Eduardo Vilar-Gomez et al. JOURNAL OF HEPATOLOGY
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies
- (2018) Angela M Wood et al. LANCET
- Diagnosis of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Non-invasive tests are enough
- (2018) Laurent Castera LIVER INTERNATIONAL
- Liver fibrosis scores predict liver disease mortality in the United States population
- (2017) Aynur Unalp-Arida et al. HEPATOLOGY
- Serum vascular cell adhesion molecule-1 predicts significant liver fibrosis in non-alcoholic fatty liver disease
- (2017) S Lefere et al. INTERNATIONAL JOURNAL OF OBESITY
- Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese PopulationClinical Perspective
- (2016) Xueli Yang et al. CIRCULATION
- Nonalcoholic fatty liver disease is associated with coronary artery calcification: A systematic review and meta-analysis
- (2016) Veeravich Jaruvongvanich et al. DIGESTIVE AND LIVER DISEASE
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
- (2016) Giovanni Targher et al. JOURNAL OF HEPATOLOGY
- Nonalcoholic Fatty Liver Disease
- (2015) Mary E. Rinella JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk
- (2013) David C. Goff et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Obesity and Metabolic Syndrome in Korea
- (2012) Sang Woo Oh Diabetes & Metabolism Journal
- HBV genotypes: relevance to natural history, pathogenesis and treatment of chronic hepatitis B
- (2011) Beom Kyung Kim et al. ANTIVIRAL THERAPY
- Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
- (2010) Giovanni Targher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Validity of real time ultrasound in the diagnosis of hepatic steatosis: A prospective study
- (2009) Srinivasan Dasarathy et al. JOURNAL OF HEPATOLOGY
- Association between angiotensin II type 1 receptor polymorphisms and the occurrence of nonalcoholic fatty liver disease
- (2009) Masato Yoneda et al. LIVER INTERNATIONAL
- Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome
- (2008) Hyeon Chang Kim et al. ATHEROSCLEROSIS
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started